Orchestra BioMed Holdings, Inc.: Financial Report Shows Revenue Struggles by Terry Bingman 28.03.2024 Orchestra BioMed Holdings, Inc. financial report: Stock closed at $5.00, 52-week range $4.26-$23.39, market cap $188.013M. No dividends. Latest data ...